The UCLA Department of Urology provides cutting edge diagnosis and treatments, and supports a staff of renowned physicians, surgeons and researchers. Demonstrating continued excellence in the field of Urology, the UCLA Department of Urology along with its varied Centers of Excellence, is often the subject of stories in newspapers, magazines, and journals. The Department also frequently issues news releases to keep the community informed on the latest developments in urology, the treatments available at UCLA, and various milestones within the Department. We include here a collection of recent stories, and an archive of older articles, for your further information.
Best in the West and No. 4 in the Nation
UCLA Urology ranks as one of the top four in the nation by U.S.News & World Report for over 20 years. To be included on the Best Hospitals Honor Roll, a medical center must be ranked very high in at least six of the 16 specialties.
Article on health.usnews.com > | Story on uclahealth.org >
Sep 19, 2017
Dr. Jeffrey Veale -- By Enrique Rivero featuring Dr. Jeffrey Veale. In 2014 a former judge from San Diego County approached the UCLA Kidney Transplant Program with an unusual request: If the judge donated a kidney to a stranger now, could his then-4-year-old grandson, who suffered from chronic kidney disease, receive priority for a future kidney transplant if needed later in life?
Story on newsroom.ucla.edu >
Aug 24, 2017
Dr. Christopher Saigal -- Dr. Christopher Saigal, vice chair of urology, was quoted in a Men's Health story on tips to reduce the risk of cancer. Saigal is a member of the UCLA Jonsson Comprehensive Cancer Center.
Story on menshealth.com >
Jul 03, 2017
Dr. Mark Litwin -- Prostate cancer diagnosis and treatment have evolved. Here’s where we are:
Dr. Mark Litwin, Chair of UCLA Urology, has just published a review of the diagnosis and treatment of prostate cancer in JAMA.
View Prostate Cancer Blog Post >.
Aug 03, 2017
Dr. Christopher Saigal -- Software helps prostate cancer patients decide on treatment. Recent research in the Journal of Clinical Oncology shows that as many as 15 percent of prostate cancer patients later regret their treatment choice. Such difficulties led Dr. Christopher Saigal, vice chair of urology at UCLA, to develop a tool to simplify the choices for men and reduce what he calls “decisional conflict,” when patients experience stress about which treatment — and consequent risks — to choose. Story on newsroom.ucla.edu > Additional Coverage: Medical Xpress | MyScience.org
Jul 26, 2017
Dr. Jesse Mills -- Health.com featured Dr. Jesse N. Mills, associate clinical professor and director of The Men’s Clinic at UCLA, in their articles on posthumous sperm retrieval, a way a man can father a child even after his death.
Jul 19, 2017
Dr. Jeffrey Veale -- What is the process after an organ donor passes away? VICE published a story on the process of organ donation, featuring Dr. Jeffrey Veale, director of the UCLA Kidney Exchange Program at the David Geffen School of Medicine at UCLA. The piece appears in VICE’s new health and wellness section, called Tonic.
Jul 12, 2017
Dr. Christopher Saigal -- Dr. Christopher Saigal, professor and vice chair in the department of urology at the David Geffen School of Medicine at UCLA, was quoted in a Los Angeles Times story about a study finding that surgery to remove early-stage prostate cancer does not lead to longer life. Saigal is a member of the UCLA Jonsson Comprehensive Cancer Center.
Jun 07, 2017
Dr. Jesse Mills -- Dr. Jesse Mills, clinical professor of urology and director of The Men’s Clinic at UCLA, explained male factor infertility June 7 on the Huffington Post’s “IVFML: A Podcast About Infertility,” a miniseries in which senior editor Anna Almendrala and her husband, Simon Ganz, discuss infertility, miscarriage and IVF as they share the story of their journey toward parenthood. Mills is featured in Episode 4: The Blame Game.
May 08, 2017
Dr. Christopher Saigal -- Dr. Christopher Saigal, vice chair of urology at the David Geffen School of Medicine at UCLA and member of UCLA’s Jonsson Comprehensive Cancer Center, was quoted May 8 in the Pittsburgh Post-Gazette about the latest diagnostic tools and treatments available for a Pittsburgh Pirates pitcher possibly facing a testicular cancer diagnosis.
Apr 17, 2017
Dr. Mark Litwin -- KQED.org on April 17 aired a segment on new guidelines from the U.S. Preventive Services Task Force on prostate cancer screening, with Dr. Mark Litwin joining as a featured expert. Litwin is chair of urology at the David Geffen School of Medicine at UCLA and a member of UCLA’s Jonsson Comprehensive Cancer Center.
Apr 18, 2017
Dr. Andrew Goldstein -- UCLA researcher Dr. Andrew Goldstein has been awarded a research scholar grant from the American Cancer Society to fund his work on prostate cancer. Goldstein is an assistant professor in residence in the departments of Urology and Molecular, Cell and Developmental Biology, and a member of UCLA’s Jonsson Comprehensive Cancer Center and Broad Stem Cell Research Center. Story on cancer.ucla.edu >
Apr 07, 2017
Dr. Jeffrey Veale -- Reuters Health reported April 7 on research led by Dr. Jeffrey Veale, director of the UCLA Kidney Exchange Program at the David Geffen School of Medicine at UCLA, finding that kidney transplant vouchers for future transplants could reduce the long waiting list for organs in the United States. Reuters U.K.; Business Insider; the web sites of WMGI-FM, Terre Haute, Indiana, and WNMT-AM, Hibbing, Minnesota; and other outlets carried the article. Tonic, part of Vice Media, also featured the study, quoting co-author Amy Waterman, associate professor-in-residence in the division of nephrology at the David Geffen School of Medicine. Waterman is also director of the Transplant Research and Education Center at UCLA.
Apr 04, 2017
Dr. Hans Gritsch -- Oldest Living Kidney Donor-Recipient Pair Celebrates 50 Years. In 1967, Ted and Denice Lombard made history, becoming one of the first father-daughter duos to undergo successful kidney transplant surgery in the United States. WFMZ-TV, Philadelphia, on May 3 featured the story of Ted and Denice Lombard, who in 1967 at UCLA became one of the first father-daughter duos to undergo successful kidney transplant surgery in the United States. View Video Story > | Story on uclahealth.org > | Additional Coverage: KADN, KQTV
Mar 20, 2017
Dr. Mark Litwin -- Dr. Mark Litwin, chair of urology at the David Geffen School of Medicine at UCLA and a member of UCLA’s Jonsson Comprehensive Cancer Center, was quoted March 20 in a MensHealth.com story on testicular cancer and other health issues for which men in their 20s should keep an eye out.
Mar 09, 2017
Dr. Jesse Mills -- Buzzfeed on March 9 and the U.K’s Daily Mail on March 6 published stories about three friends – each married with two children – who underwent vasectomies together at UCLA as a gift to their wives. Dr. Jesse Mills, clinical professor of urology and director of The Men’s Clinic at UCLA, performed the procedures and is quoted. Additional Coverage: Refinery29; Mar. 10 on Redbook; Mar. 12 on KCNC-TV in Denver; Mar. 13 on Yahoo!, Babyology, Daily Toast, and WJXT-TV in Jacksonville; Mar. 14 on KGTV-TV in San Diego; Mar. 15 on Inside Edition and WPVI-TV in Philadelphia; Mar. 16 on WDIV-TV in Detroit; March 21 on WGN-TV in Chicago; Mar. 19 in Healthline; and Mar. 23 in Fox News Health, and Connect.uclahealth.org >
Mar 08, 2017
Dr. Jesse Mills -- Dr. Jesse Mills, clinical professor of urology and director of The Men’s Clinic at UCLA, commented March 8 in Kansas City Star and March 7 in the U.K’s Daily Mail about the popularity of men getting vasectomies around the time of college basketball tournament season. Additional Coverage: Online and broadcast outlets continued to share the story of three friends who underwent vasectomies together at The Men’s Clinic at UCLA. Dr. Jesse Mills, clinical professor of urology and director of The Men’s Clinic, was featured. Coverage ran March 23 on MSN.com, March 24 in the New York Post, and March 30 on WFMZ-TV, Philadelphia and three other local news stations. WFMZ-TV.
Jan 02, 2017
Dr. Jeffrey Veale -- UCLA kidney transplant chain participants who were part of the Donate Life contingent at the 2017 Rose Parade were featured in news coverage about the annual New Year’s Day parade. Coverage included reports Jan. 2 in the Los Angeles Times; Dec. 31 on KTLA-TV (at the 2:35 mark); Dec. 28 in the Pasadena Star-News; Dec. 21 on KABC-TV, KVEA-TV, KCRA-TV, and La Opinión; and Dec. 7 in BroadwayWorld.com. Dr. Jeffrey Veale, director of the UCLA Kidney Exchange Program, was featured in the KTLA report. Story on latimes.com > | View Video > | Story on transplants.ucla.edu >
Dec 23, 2016
Dr. Jesse Mills -- Dr. Jesse Mills, Director of The Men’s Clinic at UCLA, explains, “Vasectomy is a much less invasive procedure than surgical options for women. From prep time to clean up it takes less than half an hour, and the recovery time is very short. Women either have to stay on hormonal birth control or go through tubal ligation which is more invasive than vasectomy.”
Story on blogs.babycenter.com >
Dec 08, 2016
Dr. Andrew Goldstein -- Technology.org, Medical News Today, MedicalXpress, and News-Medical.Net reported Dec. 7, and Bio Portfolio, Science Daily and Dolphnsix News reported Dec. 6 on a study finding that the progenitor cells located in unusually high numbers in inflamed areas of the prostate can increase the risk for cancer. Dr. Andrew Goldstein, assistant professor of urology at the David Geffen School of Medicine at UCLA was lead author of the study and was quoted. Goldstein is also a member of UCLA’s Jonsson Comprehensive Cancer Center and the Eli and Edythe Broad Center of Regenerative Medicine & Stem Cell Research.
Story on technology.org > Additional Coverage: Urology Times >
Nov 20, 2016
Dr. Mark Litwin -- Dr. Litwin, chair of urology at the David Geffen School of Medicine and a member of UCLA’s Jonsson Comprehensive Cancer Center, was quoted Nov. 20 by Inquisitr about prostate cancer, second opinions and treatment options.
Story on inquisitr.com >
Oct 04, 2016
Dr. Christopher Saigal -- Dr. Christopher Saigal, professor and vice chair of the UCLA Department of Urology and member of UCLA’s Jonsson Comprehensive Cancer Center, was featured Oct. 4 in a KNX-AM report on the controversy surrounding the prostate-specific antigen (PSA) test following reports that actor Ben Stiller underwent the test and was diagnosed with prostate cancer.
Story on KNX-AM >
Sep 14, 2016
Dr. Christopher Saigal -- Dr. Christopher Saigal, professor and vice chair of the UCLA Department of Urology, was quoted Sept. 14 in a Los Angeles Times story about a New England Journal of Medicine study of prostate cancer patients followed for ten years and randomly selected for treatment that included surgery and radiation or active monitoring. Researchers at Oxford determined that the incidents of death were low and there were no significant differences among treatments, only that surgery and radiation had lower rates of the disease spreading. Saigal is also a member of the UCLA Jonsson Comprehensive Cancer Center.
Story on latimes.com >
Sep 13, 2016
STAT editorial lauds kidney voucher program -- STAT published Sept. 13 an opinion piece by Dr. Sally Satel, a doctor and author, praising UCLA’s kidney voucher program, under which one can donate a kidney to a stranger in exchange for a voucher ensuring a future kidney for a loved one who may need a transplant. Satel, a kidney recipient herself, noted that the program could help increase the number of organ donors.
Story on statnews.com >
Sep 06, 2016
Dr. Christopher Saigal -- Dr. Christopher Saigal, professor and vice chair of the UCLA Department of Urology, is an author on the new article "Public Reporting of Hospital-Level Cancer Surgical Volumes in California: An Opportunity to Inform Decision Making and Improve Quality" published in the Journal of Oncology Practice.
Story on jop.ascopubs.org >
Sep 01, 2016
Dr. Leonard S. Marks -- Dr. Leonard Marks, professor of urology and director of the UCLA Active Surveillance Program, commented Sept. 1 in the U.K.’s Mirror on a study about a potential laser treatment for prostate cancer.
Story on mirror.co.uk >
Aug 19, 2016
Dr. Aaron Laviana -- High-intensity focused ultrasound (HIFU) has been viewed by some prostate cancer patients as a holy grail of sorts – the therapy is used to kill the cancer with heat without requiring the removal of the prostate gland. Potentially, that’s a big advantage for patients because prostatectomy – or removal of the prostate - can result in debilitating side effects such as erectile dysfunction and urinary and bowel incontinence.
Aug 03, 2016
Dr. Jeffrey Veale -- The Wall Street Journal: An innovative voucher program started in 2014 at UCLA is spreading across the country. The numbers are staggering. Because of a lack of donor kidneys, an average of 13 people die every day while waiting for a transplant. There are more than 100,000 names on the kidney waiting list in the U.S. and another 30 million people with chronic kidney disease who are at risk of joining them. More than 85% of those on the waiting list in 2015 are still waiting.
Story on wsj.com >
Jul 27, 2016
Dr. Shlomo Raz --Dr. Shlomo Raz commented July 27 in U.S. News & World Report on the dangers of using mesh to repair vaginal prolapse. Raz is a professor of urology and director of pelvic medicine and reconstructive surgery.
Jul 27, 2016
Dr. Jesse Mills -- The Pasadena Journal July 27 reported on urologist Dr. Jesse Mills debunking the top five myths associated with vasectomies. Mills is a clinical professor of urology and director of The Men's Clinic at UCLA. Men can be very concerned about what happens during, and after, a vasectomy - specifically how it will affect them personally.
Story on pasadenajournal.com >
Jul 11, 2016
Dr. Jeffrey Veale -- A new program launched by the UCLA Kidney and Pancreas Transplant Program in which one can donate a kidney to a stranger in exchange for a "voucher" that a donor's loved one can use in the future when he or she needs a kidney transplant garnered extensive media attention. An NBC News Channel report ran July 11 on WGN-TV (Chicago), KXAS-TV (Dallas) and WHDH-TV (Boston); July 12 on WBAL-TV (Baltimore), KVVU-TV (Las Vegas) and KSTU-TV (Salt Lake City), July 14 on Fox News Health and about 200 other television stations and media outlets across the country. Dr. Jeffrey Veale, director of the UCLA Kidney Exchange Program, commented.
Story on news3lv.com >
Jun 13, 2016
Dr. Leonard S. Marks -- A pioneering therapy using high powered laser beams may cure prostate cancer, according to research. The sci-fi style technology doesn't require surgery and has already been successful in zapping the tumours of 19 men. It 'fuses' an MRI (magnetic resonance imaging) scanner with ultrasound to identify diseased cells. A precisely targeted laser fibre is then heated up to annihilate them. Urologist Professor Leonard Marks, of the University of California, Los Angeles, said: 'Our feeling was if you can see prostate cancer using the fusion MRI and can put a needle in the spot to biopsy it, why not stick a laser fibre in the tumour the same way to kill it.
Story on dailymail.co.uk >
Jun 10, 2016
Dr. Leonard S. Marks -- Prostate cancer patients may soon have a new option to treat their disease: laser heat. UCLA researchers have found that focal laser ablation - the precise application of heat via laser to a tumor - is both feasible and safe in men with intermediate risk prostate cancer.
Story on eurekalert.org >
Mar 06, 2016
Dr. Jesse Mills -- BuzzFeed’s, The Try Guys visited The Men's Clinic at UCLA to discuss male infertility with Dr. Jesse Mills, clinic director and a clinical professor of urology. They had their sperm analyzed to assess whether they were fertile. Both a video and story were posted March 6 on BuzzFeed. So far, the video has been viewed 4.5 million times on youtube.com and Facebook.
Video on buzzfeed.com > | Video on youtube.com >
Mar 02, 2016
Dr. Jonathan Bergman -- UCLA researchers found inflated charges and significant variation in patterns of payments for surgical care by the Centers for Medicare & Medicaid Services (CMS). That charges were inflated compared with payments disproportionately affects the underinsured and uninsured, who often must pay for their care out of pocket. Surprisingly, the study found that it's not what's happening in the operating room that is driving the payment variations, but procedures that are being done in outpatient clinics.
Article on eurekalert.org >
Feb 22, 2016
Dr. Mark Litwin
Imperial Valley News reported Feb. 18 on a study by Dr. Hung-Jui Tan about geriatric events such as falling or dehydration impacting the elderly who undergo cancer surgery. Dr. Mark Litwin, chairman of the UCLA Department of Urology, was senior author.
Dec 02, 2015
Dr. Karim Chamie on Newsmax -- Active Surveillance Study Grabs Headlines
The findings, by the University of California -Los Angeles, suggests the growing number of men diagnosed with low-risk prostate cancer who avoid surgery or radiation to avoid the debilitating potential side effects may be putting themselves in danger. Oncology Nurse Advisor -- Patients With Prostate Cancer Receiving Active Surveillance May Not Be Properly Monitored. UPI.com -- Men who skip aggressive prostate cancer treatment not following-up enough.
Additional Coverage: KPCC 89.3 FM and here, United Press International, Oncology Nurse Advisor, HealthCanal, Examiner.com, MedicalXpress and Science Codex, Big News Network, NewsMax, Medical News Today and Prostate Cancer News Today, and Cancer Network, Telegraph Times and Examiner Post, reported on a study by Dr. Karim Chamie that found most men on active surveillance for prostate cancer are not being monitored properly. Chamie is an assistant professor of urology at the David Geffen School of Medicine at UCLA and a member of UCLA’s Jonsson Comprehensive Cancer Center.
Nov 03, 2015 - UCLA researchers find a wide variation in costs to treat low-risk prostate cancer
Medical News Today, DotMed.com, News-Medical.net, MedicalXpress, Health News Digest, My Informs, Examiner.com, Health Headlines and Newspaper Post Nov. 3, AJMC, ASCO Post, RadOnc Weekly, Wn.com and Topix Nov. 4, and Medscape, MDLinx and HealthCanal Nov. 5 and Urology Times Nov. 17, reported on a study by Dr. Aaron Laviana that analyzed the costs of treating low risk prostate cancer. Laviana is a fifth year urology resident.
Aug 27, 2015
The Hollywood Reporter magazine, By Jeanie Pyun - These UCLA Urology specialists — all vetted by Castle Connolly for THR's annual Doctors Issue — are whom the likes of Seth MacFarlane, Nigel Lythgoe and, yes, even Charlie Sheen see when they need career- and life-saving medical expertise. The listed UCLA Urology doctors rank in the nation’s top 10 percent and are among the very best in their specialties and communities.
Aug 11, 2015
Dr. Jonathan Bergman -- An OncLive story featured Dr. Jonathan Bergman, an assistant professor of urology and family medicine at the Veterans Health Affairs of Greater Los Angeles and the David Geffen School of Medicine at UCLA, in a story about palliative care for prostate cancer patients.
Article on onclive.com >
Jul 06, 2015
Dr. Mark Litwin & Dr. Leonard S. Marks -- Observation not aggressive treatment appropriate for many prostate cancers. Monitoring men with very low- and low-risk prostate cancers using watchful waiting or active surveillance, called expectant management, is a useful approach for a large number of men with localized tumors and could spare them the debilitating side effects of aggressive treatments that are too often unnecessarily used in this patient population, a UCLA review of common practices in prostate cancer has found.
Story on medicalxpress.com > Additional Coverage: examiner.com | Watchful Waiting & Active Surveillance at UCLA
Jun 25, 2015
Dr. Timothy Daskivich -- (HealthDay) An age-adjusted prostate cancer-specific comorbidity index (PCCI) can stratify the risk of long-term nonprostate cancer-related mortality, according to a study published in the July issue of The Journal of Urology. Timothy J. Daskivich, M.D., from the David Geffen School of Medicine at the University of California-Los Angeles, and colleagues sampled 1,598 men diagnosed with prostate cancer between 1998 and 2004.
Story on medicalxpress.com > Additional Coverage: empr.com | doctorslounge.com
Dr. Ja-Hong Kim -- UCLA Urologist, Dr. Ja-Hong Kim, has been selected as a 2015 Exceptional Physician at UCLA. She was chosen for her outstanding commitment to patients and demonstration of UCLA values: Compassion, Respect, Excellence, Discovery, Integrity and Teamwork. About Dr. Ja-Hong Kim >
Mar 17, 2015
Dr. Christopher Filson -- Uro Today on May 17, OncLive , News-Medical.net and PharmiWeb on May 18 and MedPage Today May 19 reported on a study by Dr. Christopher Filson that found biopsy guided by a fusion of magnetic resonance imaging and ultrasound improves detection of aggressive prostate cancer compared with mapping or targeting alone. Filson, a UCLA urologic oncology and health services research fellow, presented the findings at the American Urology Association meeting in New Orleans.
May 05, 2015
Dr. Christopher Filson -- Dr. Christopher Filson, a UCLA urologic oncology and health services research fellow, commented in a May 5 Renal and Urology News story about doctors prescribing pharmacotherapy to treat lower urinary tract symptoms related to benign prostatic hyperplasia.
Mar 10, 2015
Dr. Alan Kaplan -- How much does health care really cost? UCLA researchers have for the first time described cost across an entire care process for a common condition called benign prostate hyperplasia (BPH) using time-driven activity-based costing. They found a 400 percent discrepancy between the least and most expensive ways to treat the condition.
Article on newswise.com > Additional Coverage: Medicalxpress.com
Feb 19, 2015
Dr. Karim Chamie -- (HealthDay News) Study also raises concerns about possible overuse of radiation therapy. New research suggests that a wait-and-watch approach for prostate cancer isn't being used often enough, and that more men are being treated than may be necessary. Additionally, the researchers expressed concern about the numbers of men being treated with radiation therapy, regardless of their tumor specifics. "Too many men are being treated for prostate cancer, and too many are being treated with radiation therapy," said study lead author Dr. Karim Chamie, an assistant professor of urology at the University of California, Los Angeles.
Article on consumer.healthday.com >
Jan 14, 2015
Dr. Timothy Daskivich -- Researchers who studied prostate cancer (PCa) patients receiving care in the Veterans Affairs (VA) healthcare system found no significant differences in tumor burden, treatment choice, and survival outcomes between black and white men. “The observed lack of disparity in outcomes between African Americans and Caucasians may be due to their receipt of care in the equal-access VA healthcare system, which may eliminate or reduce major barriers in access to care for African Americans,” the investigators, led by Timothy J. Daskivich, MD, of the University of California, Los Angeles, wrote in a new online report in Prostate Cancer and Prostatic Disease.
Story on renalandurologynews.com >
Jan 10, 2015
Dr. Leonard S. Marks -- In 2014, prostate cancer was the leading cause of newly diagnosed cancers in men and the second leading cause of cancer death in men. Writing in the 6 January 2015 issue of the journal Prostate Cancer and Prostatic Disease, a team of scientists and physicians from the University of California, San Diego School of Medicine, with counterparts at University of California, Los Angeles, describe a novel imaging technique that measurably improves upon current prostate imaging – and may have significant implications for how patients with prostate cancer are ultimately treated.
Story on domain-b.com > | Targeted Prostate Biopsy >
Jan 06, 2015
Dr. Robert Reiter -- Scientists at UCLA and UC San Diego reported today that a new imaging system is providing more precise data on prostate cancer, the second leading cause of death in men. In today’s issue of the journal Prostate Cancer and Prostatic Disease, the researchers said current magnetic resonance imaging systems have flaws, but a restriction spectrum imaging MRI corrects them, allowing physicians to accurately plot a tumor’s location and extent. “If by imaging we could predict the tumor grade, we may be able to spare some patients from prostate resection and monitor their cancer with imaging,” said Dr. Robert Reiter, a professor of urology at UCLA.
Story on westsidetoday.com > Additional Coverage: health.ucsd.edu, mynewsla.com